Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Neovasc Inc (NVCN)

Neovasc Inc (NVCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 82,375
  • Shares Outstanding, K 2,743
  • Annual Sales, $ 3,810 K
  • Annual Income, $ -41,200 K
  • 60-Month Beta 1.70
  • Price/Sales 21.30
  • Price/Cash Flow N/A
  • Price/Book 5.20
Trade NVCN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -14.34
  • Most Recent Earnings $-5.04 on 03/31/23
  • Next Earnings Date 05/11/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -3.01
  • Growth Rate Est. (year over year) +33,289.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.04 +3.41%
on 03/16/23
30.07 -0.13%
on 04/10/23
+0.99 (+3.41%)
since 03/10/23
3-Month
18.18 +65.18%
on 01/11/23
30.07 -0.13%
on 04/10/23
+11.55 (+62.50%)
since 01/10/23
52-Week
4.59 +554.96%
on 06/17/22
30.07 -0.13%
on 04/10/23
+19.96 (+198.06%)
since 04/08/22

Most Recent Stories

More News
Shockwave Medical Completes Acquisition of Neovasc

Santa Clara, California--(Newsfile Corp. - April 11, 2023) - Shockwave Medical, Inc. (NASDAQ: SWAV) ("Shockwave"), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...

NVCN.TO : 40.15 (+0.58%)
SWAV : 329.85 (-0.08%)
NVCN : 30.03 (+1.66%)
Neovasc Shareholders Approve Acquisition by Shockwave Medical

Vancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive devices for the treatment...

NVCN.TO : 40.15 (+0.58%)
NVCN : 30.03 (+1.66%)
A Bull Market Is Coming: 1 Outstanding Growth Stock Down 36% to Buy and Hold

This up-and-coming medical technology star is set up to deliver market-beating gains for its long-term investors.

NVCN : 30.03 (+1.66%)
COMP : 4.33 (+0.70%)
SWAV : 329.85 (-0.08%)
Neovasc Announces German Reimbursement Renewal

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 1, 2023) - Neovasc, Inc. (NASDAQ : NVCN) (TSX : NVCN) ("Neovasc" or "the Company") today announced the German Institute...

NVCN.TO : 40.15 (+0.58%)
NVCN : 30.03 (+1.66%)
Mergers and Acquisitions in 2023 Off To A Strong Start

Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.

UNH : 517.23 (-1.41%)
LHCG : 169.81 (+0.47%)
AZN : 77.11 (+0.27%)
BNTX : 92.47 (+2.05%)
CVS : 57.40 (-0.49%)
SGFY : 30.49 (+0.07%)
MRNA : 141.01 (+6.10%)
GILD : 67.90 (+0.27%)
LPTX : 2.57 (-2.28%)
SWAV : 329.85 (-0.08%)
NVCN : 30.03 (+1.66%)
SNY : 48.42 (-0.51%)
Moore Kuehn Encourages NVCN, VLTA, CNCE, and ANGN Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

NVCN : 30.03 (+1.66%)
VLTA : 0.8590 (-0.01%)
CNCE : 8.37 (+0.12%)
ANGN : 10.0000 (+2.04%)
Neovasc (NASDAQ: NVCN) (TSX: NVCN) Enters into Agreement to be Acquired by Shockwave Medical (NASDAQ: SWAV) for $100 Million & CVR

Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) is engaged as a specialty medical device company, which is focused on the development,

NVCN : 30.03 (+1.66%)
NVCN.TO : 40.15 (+0.58%)
SWAV : 329.85 (-0.08%)
Shockwave Medical to Acquire Neovasc

Vancouver, British Columbia--(Newsfile Corp. - January 17, 2023) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive devices for the...

NVCN.TO : 40.15 (+0.58%)
NVCN : 30.03 (+1.66%)
Neovasc (NVCN) is on the Move, Here's Why the Trend Could be Sustainable

Neovasc (NVCN) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

NVCN : 30.03 (+1.66%)
Recent Price Trend in Neovasc (NVCN) is Your Friend, Here's Why

Neovasc (NVCN) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent...

NVCN : 30.03 (+1.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Neovasc Inc. is a specialty medical device company. It develops, manufactures and markets products for the cardiovascular marketplace. The Company's products include the Tiara (TM) mitral valve prosthesis in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer (TM)...

See More

Key Turning Points

3rd Resistance Point 30.90
2nd Resistance Point 30.48
1st Resistance Point 30.26
Last Price 30.03
1st Support Level 29.62
2nd Support Level 29.20
3rd Support Level 28.98

See More

52-Week High 30.07
Last Price 30.03
Fibonacci 61.8% 20.33
Fibonacci 50% 17.33
Fibonacci 38.2% 14.32
52-Week Low 4.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar